| Stage | MUSA | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.9B | 100.00% | $8.0B | 100.00% | CVNA ×1.17 |
| Gross profit | $714M | 10.36% | $1.5B | 18.92% | CVNA +8.6pp |
| Operating income | $261M | 3.78% | $714M | 8.88% | CVNA +5.1pp |
| Pre-tax income | $234M | 3.39% | $552M | 6.87% | CVNA +3.5pp |
| Net income | $176M | 2.55% | $483M | 6.01% | CVNA +3.5pp |
| Stage | MUSA | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $6.9B100.00% | $8.0B100.00% | CVNA ×1.17 |
| Gross profit | 10.36%$714M | 18.92%$1.5B | CVNA +8.6pp |
| Operating income | 3.78%$261M | 8.88%$714M | CVNA +5.1pp |
| Pre-tax income | 3.39%$234M | 6.87%$552M | CVNA +3.5pp |
| Net income |
| 2.55%$176M |
| 6.01%$483M |
| CVNA +3.5pp |
No shared counterparties.